Skip to main content

Massachusetts-based drug maker Moderna will build an mRNA vaccine manufacturing plant in Canada within the next two years, says CEO Stéphane Bancel. The company has signed a memorandum of understanding with the federal government that will result in Canada becoming the home of Moderna's first foreign operation.

The Canadian Press